Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atropine for prevention of vasovagal syncope before spinal anesthesia
IRCT20191231045957N1Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Jan 2020
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of atropine in Neurocardiogenic syncope (NCS) (2 arms), sponsored by Islamic Azad University. Primary endpoints: Association between vasovagal syncope and atropine injection by age, Association between vasovagal syncope and atropine injection by sex and 4 more. Started Jan 2020; status: completed.
02
Drugs
atropine
03
Conditions
Neurocardiogenic syncope (NCS)
Beyond the preview
Go deeper on IRCT20191231045957N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191231045957N1.